CTKB Q3 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$52M+1.5% YoY

Gross Profit

$28M52.7% margin

Operating Income

-$9M-17.6% margin

Net Income

-$5M-10.5% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+14.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$495M

Total Liabilities

$116M

Stockholders' Equity

$379M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$52M	+1.5%
Gross Profit	$28M	$29M	-5.0%
Operating Income	-$9M	-$4M	-116.4%
Net Income	-$5M	$941,000	-682.1%

Revenue Segments

Service

$43M53%

Product

$38M47%

Geographic Segments

UNITED STATES

$27M52%

EMEA

$12M24%

Asia Pacific

$11M21%

Other

$2M3%